H. Manning
Faculty Member
Last active: 3/22/2018

  1. A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs. Xie J, Wang C, Virostko J, Manning HC, Pham W, Bauer J, Gore JC (2013) Chembiochem 14(12): 1494-503
    › Primary publication · 23881799 (PubMed) · PMC3819221 (PubMed Central)
  2. 3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer. McKinley ET, Smith RA, Zhao P, Fu A, Saleh SA, Uddin MI, Washington MK, Coffey RJ, Manning HC (2013) J Nucl Med 54(3): 424-30
    › Primary publication · 23341544 (PubMed) · PMC3633462 (PubMed Central)
  3. Simultaneous PET-MRI in oncology: a solution looking for a problem? Yankeelov TE, Peterson TE, Abramson RG, Izquierdo-Garcia D, Garcia-Izquierdo D, Arlinghaus LR, Li X, Atuegwu NC, Catana C, Manning HC, Fayad ZA, Gore JC (2012) Magn Reson Imaging 30(9): 1342-56
    › Primary publication · 22795930 (PubMed) · PMC3466373 (PubMed Central)
  4. Rapid, Microwave-Assisted Organic Synthesis of Selective (V600E)BRAF Inhibitors for Preclinical Cancer Research. Buck JR, Saleh S, Uddin MI, Manning HC (2012) Tetrahedron Lett 53(32): 4161-4165
    › Primary publication · 23180892 (PubMed) · PMC3501741 (PubMed Central)
  5. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC (2012) J Nucl Med 53(2): 287-94
    › Primary publication · 22251555 (PubMed) · PMC3391587 (PubMed Central)
  6. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Myers MV, Manning HC, Coffey RJ, Liebler DC (2012) Mol Cell Proteomics 11(2): M111.015222
    › Primary publication · 22147731 (PubMed) · PMC3277773 (PubMed Central)
  7. Preclinical molecular imaging of the translocator protein (TSPO) in a metastases model based on breast cancer xenografts propagated in the murine brain. Wyatt SK, Manning HC, Bai M, Ehtesham M, Mapara KY, Thompson RC, Bornhop DJ (2012) Curr Mol Med 12(4): 458-66
    › Primary publication · 22348613 (PubMed) · PMC6544018 (PubMed Central)
  8. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N (2012) Oncol Rep 28(4): 1301-8
    › Primary publication · 22895640 (PubMed) · PMC3981033 (PubMed Central)
  9. Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy. Xu J, Li K, Smith RA, Waterton JC, Zhao P, Chen H, Does MD, Manning HC, Gore JC (2012) PLoS One 7(7): e41714
    › Primary publication · 22911846 (PubMed) · PMC3404000 (PubMed Central)
  10. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)